Synonyms: Synarel®
nafarelin is an approved drug (FDA (1990))
Compound class:
Peptide or derivative
Comment: Nafarelin is a gonadotropin releasing hormone receptor agonist. The structure shown here is from PubChem CID 25077405.
|
Classification ![]() |
|
Compound class | Peptide or derivative |
Approved drug? | Yes (FDA (1990)) |
International Nonproprietary Names ![]() |
|
INN number | INN |
5402 | nafarelin |
Synonyms ![]() |
Synarel® |
Database Links ![]() |
|
Specialist databases | |
GPCRdb Ligand | nafarelin |
Other databases | |
CAS Registry No. | 76932-56-4 (source: Drugbank) |
ChEMBL Ligand | CHEMBL1201309 |
DrugBank Ligand | DB00666 |
GtoPdb PubChem SID | 178100736 |
PubChem CID | 25077405 |
Search Google for chemical match using the InChIKey | RWHUEXWOYVBUCI-ITQXDASVSA-N |
Search Google for chemicals with the same backbone | RWHUEXWOYVBUCI |
Search PubMed clinical trials | nafarelin |
Search PubMed titles | nafarelin |
Search PubMed titles/abstracts | nafarelin |
UniChem Compound Search for chemical match using the InChIKey | RWHUEXWOYVBUCI-ITQXDASVSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | RWHUEXWOYVBUCI-ITQXDASVSA-N |
Wikipedia | Nafarelin |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Nafarelin (links to external site)
Cat. No. 2544 |